A listed biotech company conducting Phase III clinical trials in an oncology indication needed Chief Medical Officer support for multiple clinical activities in Europe and the United States.
We provided medical oversight of three ongoing clinical trials, in particular, providing medical oversight for a Phase I trial and preparing for:
- marketing application
- data and safety measurement board (DSMB) review of an ongoing Phase IIb clinical trial
- launch of a Phase II clinical study in pancreatic cancer